Concepedia

Xiaorui Fu

XF

Statistics

Publications

58

Citations

1.8K

H-Index

23

Active since

2013

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

Nanchang University

The University of Texas MD Anderson Cancer Center

First Affiliated Hospital of Nanchang University

Xiaorui Fu is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, immunology, and cancer research.

ORCID

Top concepts

Publications per year

2013–2024

58

Publications

58

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Xin Li, Yasong Cheng, Mingzhi Zhang et al. · Journal of Hematology & Oncology · 2018 · 194 citations · Full text

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Xin Li, Yingying Cui, Zhenchang Sun et al. · Clinical Cancer Research · 2016 · 138 citations

Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment

Xinyi Wang, Jinzhong Duanmu, Xiaorui Fu et al. · Journal of Translational Medicine · 2020 · 99 citations · Full text

c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma

Linan Zhu, Xudong Zhang, Xiaorui Fu et al. · Journal of Cellular Biochemistry · 2019 · 66 citations

, , +13

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Xinhua Wang, Lei Zhang, Xiangli Liu et al. · JAMA Oncology · 2022 · 55 citations · Full text

1–5 of 58